HSBC Holdings’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$492K Sell
49,569
-15,501
-24% -$153K ﹤0.01% 2291
2026
Q1
$632K Buy
65,070
+37,337
+135% +$342K ﹤0.01% 2103
2025
Q4
$261K Sell
27,733
-9,699
-26% -$98.7K ﹤0.01% 2581
2025
Q3
$365K Sell
37,432
-8,615
-19% -$66.2K ﹤0.01% 2249
2025
Q2
$282K Buy
46,047
+32,959
+252% +$247K ﹤0.01% 2487
2025
Q1
$160K Sell
13,088
-11,091
-46% -$157K ﹤0.01% 2686
2024
Q4
$323K Buy
24,179
+9,101
+60% +$144K ﹤0.01% 2452
2024
Q3
$245K Buy
+15,078
New +$324K ﹤0.01% 2483
2019
Q2
Sell
-43,436
Closed -$527K 2825
2019
Q1
$527K Buy
+43,436
New +$542K ﹤0.01% 2071
2017
Q1
Sell
-5,985
Closed -$294K 2483
2016
Q4
$294K Buy
+5,985
New +$330K ﹤0.01% 2250

Other funds holding PRTA

HSBC Holdings's PRTA Position: Q2 2026 in Review

HSBC Holdings reduced its Prothena Corp (PRTA) stake by 24% in Q2 2026, selling an estimated $153K and leaving 49,569 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #2291.

HSBC Holdings first reported a position in PRTA in Q4 2016 and has held it in 10 quarters since. The position peaked at $632K in Q1 2026. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • HSBC Holdings held 49,569 shares of Prothena Corp worth $492K as of Q2 2026.
  • HSBC Holdings sold 15,501 Prothena Corp shares in Q2 2026, an estimated $153K.
  • Prothena Corp made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2291 holding.
  • HSBC Holdings first reported a position in Prothena Corp in Q4 2016 and has held it in 10 quarters since.
  • HSBC Holdings's Prothena Corp position peaked at $632K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.